Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128


Immunometabolism of Phagocytes and Relationships to Cardiac Repair.

Zhang S, Bories G, Lantz C, Emmons R, Becker A, Liu E, Abecassis MM, Yvan-Charvet L, Thorp EB.

Front Cardiovasc Med. 2019 Apr 11;6:42. doi: 10.3389/fcvm.2019.00042. eCollection 2019. Review.


Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice.

First MR, Peddi VR, Mannon R, Knight R, Marsh CL, Kurian SM, Rice JC, Maluf D, Mandelbrot D, Patel A, David J, Schieve C, Lee D, Lewis P, Friedewald JJ, Abecassis MM, Rose S.

Transplant Proc. 2019 Apr;51(3):729-733. doi: 10.1016/j.transproceed.2018.10.024. Epub 2018 Dec 11.


Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function.

Marsh CL, Kurian SM, Rice JC, Whisenant TC, David J, Rose S, Schieve C, Lee D, Case J, Barrick B, Peddi VR, Mannon RB, Knight R, Maluf D, Mandelbrot D, Patel A, Friedewald JJ, Abecassis MM, First MR.

Transplant Proc. 2019 Apr;51(3):722-728. doi: 10.1016/j.transproceed.2019.01.054. Epub 2019 Jan 26.


A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Zhang Z, Qiu L, Yan S, Wang JJ, Thomas PM, Kandpal M, Zhao L, Iovane A, Liu XF, Thorp EB, Chen Q, Hummel M, Kanwar YS, Abecassis MM.

Am J Transplant. 2019 Apr 4. doi: 10.1111/ajt.15376. [Epub ahead of print]


Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.

Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, Baliga P, Odim J, Brown MM, Ikle DN, Armstrong BD, Charette JI, Brietigam SS, Sustento-Reodica N, Zhao L, Kandpal M, Salomon DR, Abecassis MM; Clinical Trials in Organ Transplantation 08 (CTOT-08).

Am J Transplant. 2019 Jan;19(1):98-109. doi: 10.1111/ajt.15011. Epub 2018 Aug 31.


Response to "Shifting the conversation on outcomes reporting".

Peipert JD, Abecassis MMI, Butt Z, Cella D, Ladner DP.

Am J Transplant. 2018 Sep;18(9):2368-2369. doi: 10.1111/ajt.14968. Epub 2018 Jun 28. No abstract available.


Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK.

Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913. No abstract available.


The "opportunity costs" of kidney transplantation.

Jay CL, Abecassis MM.

Am J Transplant. 2018 May;18(5):1044-1045. doi: 10.1111/ajt.14724. Epub 2018 Apr 6. No abstract available.


Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells.

Leventhal JR, Miller J, Mathew JM, Kurian S, Tambur AR, Friedewald J, Charrette J, Abecassis MM.

Hum Immunol. 2018 May;79(5):277-282. doi: 10.1016/j.humimm.2018.01.010. Epub 2018 Feb 1. Review.


Incidence and Risk Factors of Intracranial Hemorrhage in Liver Transplant Recipients.

Gallagher TK, Thomas KA, Ladner DP, Ganger D, Sorond FA, Prabhakaran S, Abecassis MM, Fryer JP, Liotta EM.

Transplantation. 2018 Mar;102(3):448-453. doi: 10.1097/TP.0000000000002005.



VanWagner LB, Ning H, Whitsett M, Levitsky J, Uttal S, Wilkins JT, Abecassis MM, Ladner DP, Skaro AI, Lloyd-Jones DM.

Hepatology. 2017 Dec;66(6):2089-2090. doi: 10.1002/hep.29525. Epub 2017 Nov 6. No abstract available.


A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.

VanWagner LB, Ning H, Whitsett M, Levitsky J, Uttal S, Wilkins JT, Abecassis MM, Ladner DP, Skaro AI, Lloyd-Jones DM.

Hepatology. 2017 Dec;66(6):1968-1979. doi: 10.1002/hep.29329. Epub 2017 Nov 6.


Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.

Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP.

Am J Transplant. 2017 Sep;17(9):2410-2419. doi: 10.1111/ajt.14239. Epub 2017 Apr 4.


Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.

Kurian SM, Velazquez E, Thompson R, Whisenant T, Rose S, Riley N, Harrison F, Gelbart T, Friedewald JJ, Charette J, Brietigam S, Peysakhovich J, First MR, Abecassis MM, Salomon DR.

Am J Transplant. 2017 Aug;17(8):2103-2116. doi: 10.1111/ajt.14224. Epub 2017 Apr 3.


AASLD guidelines for the treatment of hepatocellular carcinoma.

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA.

Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. No abstract available.


The impact of coronary artery disease on outcomes after liver transplantation.

Skaro AI, Gallon LG, Lyuksemburg V, Jay CL, Zhao L, Ladner DP, VanWagner LB, De Wolf AM, Flaherty JD, Levitsky J, Abecassis MM, Gheorghiade M.

J Cardiovasc Med (Hagerstown). 2016 Dec;17(12):875-885.


Exome Sequencing and Prediction of Long-Term Kidney Allograft Function.

Mesnard L, Muthukumar T, Burbach M, Li C, Shang H, Dadhania D, Lee JR, Sharma VK, Xiang J, Suberbielle C, Carmagnat M, Ouali N, Rondeau E, Friedewald JJ, Abecassis MM, Suthanthiran M, Campagne F.

PLoS Comput Biol. 2016 Sep 29;12(9):e1005088. doi: 10.1371/journal.pcbi.1005088. eCollection 2016 Sep.


Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.

Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ, Kirk AD, Salomon DR.

Am J Transplant. 2017 Mar;17(3):712-723. doi: 10.1111/ajt.14038. Epub 2016 Oct 11.


Hispanic/Latino Disparities in Living Donor Kidney Transplantation: Role of a Culturally Competent Transplant Program.

Gordon EJ, Lee J, Kang R, Ladner DP, Skaro AI, Holl JL, French DD, Abecassis MM, Caicedo JC.

Transplant Direct. 2015 Sep 22;1(8):e29. doi: 10.1097/TXD.0000000000000540. eCollection 2015 Sep.


Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients.

Patzer RE, Serper M, Reese PP, Przytula K, Koval R, Ladner DP, Levitsky JM, Abecassis MM, Wolf MS.

Clin Transplant. 2016 Oct;30(10):1294-1305. doi: 10.1111/ctr.12821. Epub 2016 Aug 29.


Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.

Wang B, Jakus AE, Baptista PM, Soker S, Soto-Gutierrez A, Abecassis MM, Shah RN, Wertheim JA.

Stem Cells Transl Med. 2016 Sep;5(9):1257-67. doi: 10.5966/sctm.2015-0235. Epub 2016 Jul 15.


Comparative top down proteomics of peripheral blood mononuclear cells from kidney transplant recipients with normal kidney biopsies or acute rejection.

Savaryn JP, Toby TK, Catherman AD, Fellers RT, LeDuc RD, Thomas PM, Friedewald JJ, Salomon DR, Abecassis MM, Kelleher NL.

Proteomics. 2016 Jul;16(14):2048-58. doi: 10.1002/pmic.201600008.


Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.

Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR.

Am J Transplant. 2016 Jul;16(7):1982-98. doi: 10.1111/ajt.13728. Epub 2016 Mar 15.


The hospital pager: Out with the old or here to stay?

McElroy LM, Gillett EZ, Nguyen C, Holl JL, Abecassis MM, Ladner DP.

Clin Liver Dis (Hoboken). 2016 Feb 26;7(2):29-31. doi: 10.1002/cld.529. eCollection 2016 Feb. Review. No abstract available.


Applying the WHO conceptual framework for the International Classification for Patient Safety to a surgical population.

McElroy LM, Woods DM, Yanes AF, Skaro AI, Daud A, Curtis T, Wymore E, Holl JL, Abecassis MM, Ladner DP.

Int J Qual Health Care. 2016 Apr;28(2):166-74. doi: 10.1093/intqhc/mzw001. Epub 2016 Jan 23.


Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.

Grant JL, Hawkins C, Brooks H, Palella FJ Jr, Koppe SW, Abecassis MM, Stosor V.

AIDS. 2016 Jan 2;30(1):93-8. doi: 10.1097/QAD.0000000000000887.


Emerging Ethical Considerations of Donation After Circulatory Death: Getting to the Heart of the Matter.

Gallagher TK, Skaro AI, Abecassis MM.

Ann Surg. 2016 Feb;263(2):217-8. doi: 10.1097/SLA.0000000000001585. No abstract available.


Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers.

Leventhal JR, Mathew JM, Salomon DR, Kurian SM, Friedewald JJ, Gallon L, Konieczna I, Tambur AR, Charette J, Levitsky J, Jie C, Kanwar YS, Abecassis MM, Miller J.

Am J Transplant. 2016 Jan;16(1):221-34. doi: 10.1111/ajt.13416. Epub 2015 Jul 30.


Clinician perceptions of operating room to intensive care unit handoffs and implications for patient safety: a qualitative study.

McElroy LM, Macapagal KR, Collins KM, Abecassis MM, Holl JL, Ladner DP, Gordon EJ.

Am J Surg. 2015 Oct;210(4):629-35. doi: 10.1016/j.amjsurg.2015.05.008. Epub 2015 Jun 27.


Unintended Consequences of the New National Kidney Allocation Policy in the United States.

Tambur AR, Haarberg KM, Friedewald JJ, Leventhal JR, Cusick MF, Jaramillo A, Abecassis MM, Kaplan B.

Am J Transplant. 2015 Sep;15(9):2465-9. doi: 10.1111/ajt.13381. Epub 2015 Jul 2.


Operating room to intensive care unit handoffs and the risks of patient harm.

McElroy LM, Collins KM, Koller FL, Khorzad R, Abecassis MM, Holl JL, Ladner DP.

Surgery. 2015 Sep;158(3):588-94. doi: 10.1016/j.surg.2015.03.061. Epub 2015 Jun 9.


Early Postoperative Emergency Department Care of Abdominal Transplant Recipients.

McElroy LM, Schmidt KA, Richards CT, Lapin B, Abecassis MM, Holl JL, Adams J, Ladner DP.

Transplantation. 2015 Aug;99(8):1652-7. doi: 10.1097/TP.0000000000000781.


Targeted analysis of recombinant NF kappa B (RelA/p65) by denaturing and native top down mass spectrometry.

Savaryn JP, Skinner OS, Fornelli L, Fellers RT, Compton PD, Terhune SS, Abecassis MM, Kelleher NL.

J Proteomics. 2016 Feb 16;134:76-84. doi: 10.1016/j.jprot.2015.04.025. Epub 2015 May 4.


Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.

Lerret NM, Li T, Wang JJ, Kang HK, Wang S, Wang X, Jie C, Kanwar YS, Abecassis MM, Luo X, Zhang Z.

J Am Soc Nephrol. 2015 Nov;26(11):2753-64. doi: 10.1681/ASN.2014080813. Epub 2015 Mar 18.


Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.

Leventhal JR, Elliott MJ, Yolcu ES, Bozulic LD, Tollerud DJ, Mathew JM, Konieczna I, Ison MG, Galvin J, Mehta J, Badder MD, Abecassis MM, Miller J, Gallon L, Ildstad ST.

Transplantation. 2015 Feb;99(2):288-98. doi: 10.1097/TP.0000000000000605.


The use of technology for urgent clinician to clinician communications: a systematic review of the literature.

Nguyen C, McElroy LM, Abecassis MM, Holl JL, Ladner DP.

Int J Med Inform. 2015 Feb;84(2):101-10. doi: 10.1016/j.ijmedinf.2014.11.003. Epub 2014 Nov 15. Review.


Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation.

Caralt M, Uzarski JS, Iacob S, Obergfell KP, Berg N, Bijonowski BM, Kiefer KM, Ward HH, Wandinger-Ness A, Miller WM, Zhang ZJ, Abecassis MM, Wertheim JA.

Am J Transplant. 2015 Jan;15(1):64-75. doi: 10.1111/ajt.12999. Epub 2014 Nov 17. Erratum in: Am J Transplant. 2017 May;17 (5):1429.


Improving Geographic Equity in Kidney Transplantation Using Alternative Kidney Sharing and Optimization Modeling.

Davis AE, Mehrotra S, Friedewald JJ, Daskin MS, Skaro AI, Abecassis MM, Ladner DP.

Med Decis Making. 2015 Aug;35(6):797-807. doi: 10.1177/0272989X14557696. Epub 2014 Nov 10.


Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients.

Serper M, Patzer RE, Reese PP, Przytula K, Koval R, Ladner DP, Levitsky J, Abecassis MM, Wolf MS.

Liver Transpl. 2015 Jan;21(1):22-8. doi: 10.1002/lt.24023.


A meta-analysis of complications following deceased donor liver transplant.

McElroy LM, Daud A, Davis AE, Lapin B, Baker T, Abecassis MM, Levitsky J, Holl JL, Ladner DP.

Am J Surg. 2014 Oct;208(4):605-18. doi: 10.1016/j.amjsurg.2014.06.006. Epub 2014 Jul 18. Review.


Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation.

Levitsky J, Baker TB, Jie C, Ahya S, Levin M, Friedewald J, Al-Saden P, Salomon DR, Abecassis MM.

Hepatology. 2014 Dec;60(6):2017-26. doi: 10.1002/hep.27346. Epub 2014 Oct 29.


High early cardiovascular mortality after liver transplantation.

VanWagner LB, Lapin B, Levitsky J, Wilkins JT, Abecassis MM, Skaro AI, Lloyd-Jones DM.

Liver Transpl. 2014 Nov;20(11):1306-16. doi: 10.1002/lt.23950. Epub 2014 Oct 24.


Access to retransplantation after failed donation after circulatory death liver transplantation: eo ire itum.

Skaro AI, Zhao L, Vanwagner LB, Abecassis MM.

Am J Transplant. 2014 May;14(5):991-3. doi: 10.1111/ajt.12701. Epub 2014 Apr 14. No abstract available.


Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.

Kurian SM, Williams AN, Gelbart T, Campbell D, Mondala TS, Head SR, Horvath S, Gaber L, Thompson R, Whisenant T, Lin W, Langfelder P, Robison EH, Schaffer RL, Fisher JS, Friedewald J, Flechner SM, Chan LK, Wiseman AC, Shidban H, Mendez R, Heilman R, Abecassis MM, Marsh CL, Salomon DR.

Am J Transplant. 2014 May;14(5):1164-72. doi: 10.1111/ajt.12671. Epub 2014 Apr 11.


Culturally competent transplant program improves Hispanics' knowledge and attitudes about live kidney donation and transplant.

Gordon EJ, Reddy E, Gil S, Feinglass J, Rodde J, Abecassis MM, Caicedo JC.

Prog Transplant. 2014 Mar;24(1):56-68. doi: 10.7182/pit2014378.


The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States.

Davis AE, Mehrotra S, McElroy LM, Friedewald JJ, Skaro AI, Lapin B, Kang R, Holl JL, Abecassis MM, Ladner DP.

Transplantation. 2014 May 27;97(10):1049-57. doi: 10.1097/


The emergence of top-down proteomics in clinical research.

Savaryn JP, Catherman AD, Thomas PM, Abecassis MM, Kelleher NL.

Genome Med. 2013 Jun 27;5(6):53. doi: 10.1186/gm457. eCollection 2013.


NUTORC-a transdisciplinary health services and outcomes research team in transplantation.

Ladner DP, Alonso EM, Butt Z, Caicedo JC, Cella D, Daud A, Friedewald JJ, Gordon EJ, Hazen GB, Ho BT, Hoke KR, Holl JL, Ison MG, Kang R, Mehrotra S, Preczewski LB, Ross OA, Sharaf PH, Skaro AI, Wang E, Wolf MS, Woods DM, Abecassis MM.

Transl Behav Med. 2012 Dec;2(4):446-458.


Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization.

Salem R, Gilbertsen M, Butt Z, Memon K, Vouche M, Hickey R, Baker T, Abecassis MM, Atassi R, Riaz A, Cella D, Burns JL, Ganger D, Benson AB 3rd, Mulcahy MF, Kulik L, Lewandowski R.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1358-1365.e1. doi: 10.1016/j.cgh.2013.04.028. Epub 2013 May 2.


Opportunities for shared decision making in kidney transplantation.

Gordon EJ, Butt Z, Jensen SE, Lok-Ming Lehr A, Franklin J, Becker Y, Sherman L, Chon WJ, Beauvais N, Hanneman J, Penrod D, Ison MG, Abecassis MM.

Am J Transplant. 2013 May;13(5):1149-58. doi: 10.1111/ajt.12195. Epub 2013 Mar 14. Review.

Supplemental Content

Loading ...
Support Center